Alkourainy, Kousay

Alkourainy, Kousay was paid $8.35M by Medicaid between Jan 2018 and Dec 2021, across 24 billing codes. Its largest line is J2505, Injection, pegfilgrastim, 6 mg — 43% of everything it billed.

33Billing provider infoALKOURAINY, KOUSAY
CHULA VISTA, CA 91910

33aNPI1457361271assigned 08/08/2006

33bProvider typeHematology & Oncology Physician

28Total paid$8.35M

24GClaims32,104

24DCodes billed24

24AFirst – last monthJan 2018 – Dec 2021

Compared with peers

Next to other Hematology & Oncology Physician providers in California

Rank by total paid#2 of 180

Median peer was paid$26K

This provider vs. median325×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	11,250	$3.07M
2019	12,296	$3.90M
2020	6,730	$1.26M
2021	1,828	$118K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J2505	Injection, pegfilgrastim, 6 mg	43%	906	551	$3.61M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	38%	785	437	$3.17M
J1453	Injection, fosaprepitant, 1 mg	4.8%	1,554	806	$398K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.9%	6,464	6,119	$329K
J9202	Goserelin acetate implant, per 3.6 mg	2.6%	452	407	$217K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.8%	3,093	1,890	$152K
96367		1.2%	1,695	994	$104K
96415		1.2%	1,659	1,124	$100K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,020	1,013	$48K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,427	742	$38K
96417		<1%	917	668	$31K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	5,480	3,716	$25K

12 more codes

J1442	Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram	<1%	53	$22K
J3489	Injection, zoledronic acid, 1 mg	<1%	477	$22K
96368		<1%	1,484	$21K
J9171	Injection, docetaxel, 1 mg	<1%	94	$20K
J9070	Cyclophosphamide, 100 mg	<1%	29	$13K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	27	$9K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,737	$7K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	440	$6K
99205	Prolong outpt/office vis	<1%	44	$5K
99070		<1%	802	$4K
96402		<1%	444	$4K
96401		<1%	21	$112.98

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.